Dabur Pharma Limited is using the services of Dabur Research Foundation (DRF), for Research & Development activities. DRF is an independent research organization recognized by the Department of Science and Technology, Government of India.

The Company's finished dosage forms are manufactured at most modern manufacturing units in Bordon (U.K.) and Baddi (India), while the active pharmaceutical ingredients (APIs) are manufactured at Kalyani (India). Some of the products are also manufactured by Dabur India Limited at their Sahibabad facilities (India)..

The Bordon Facilities have been granted a manufacturing license by the MHRA, UK. These facilities use the unique isolator technology and are one of the best in Europe. The Baddi facilities are approved by the regulatory bodies of countries like Brazil, Colombia, Malaysia, Turkey, Pakistan, Ukraine, Sudan, Belarus Hungary, Jordan, Zimbabwe, Yemen. APIs manufacturing facilities at Kalyani has approvals by TGA, Australia and USFDA.

The Company has also set up overseas offices in the UK, Malaysia, Russia, Thailand and Philippines. Offices are also being set up in Brazil and US.

Over the years, the Company has strived hard to strategically position itself as a global player in the field of anticancer (oncology) formulations and provide high quality products supported by superior level of customer services, at highly competitive prices.